Claris Bio appointed Stephen Brady to lead advanced development, while Severino leads Tessera Therapeutics amid competitive challenges.
1 report, 1 independent
Updated Jul 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Claris Bio appointed Stephen Brady to lead advanced development, while Severino leads Tessera Therapeutics amid competitive challenges.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Stephen Brady
researcher
Nothing else this week.
-
Severino
bishop of the Roman Catholic Church
Nothing else this week.